4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-142069
Chief Financial Officer acquired 4,790 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2016-09-15 | Other acquisition | +4,790 | 142,702 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…